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Clinical Outcomes After Both Coronary Calcium
Scanning and Exercise Myocardial Perfusion
Scintigraphy
Alan Rozanski, MD, FACC,* Heidi Gransar, MS,† Nathan D. Wong, PHD, FACC,‡
Leslee J. Shaw, PHD,† Romalisa Miranda-Peats, MPH,† Donna Polk, MD,† Sean W. Hayes, MD,†
John D. Friedman, MD, MPH, FACC,† Daniel S. Berman, MD, FACC†
New York, New York; and Los Angeles and Irvine, California
Objectives The purpose of this work was to assess the prognosis in patients undergoing both coronary artery calcium (CAC)
scanning and exercise myocardial perfusion scintigraphy (MPS).
Background Whereas the prognostic effectiveness of MPS is well established, recent studies indicate that quantification of
CAC also predicts cardiac outcomes. However, prognostic information is not yet available upon which to guide
the management of patients who have had both tests.
Methods We assessed the frequency of cardiac death and myocardial infarction over a mean follow-up of 32  16
months in 1,153 patients undergoing both CAC scanning and MPS. Results were compared with those from a
referent cohort of 9,308 patients who had earlier undergone MPS only.
Results The frequency of myocardial ischemia rose with increasing CAC scores (p  0.001), but ischemia was present in
only 64 patients. Among the 1,089 nonischemic patients, of which only 3 (0.3%) underwent early revasculariza-
tion, the annualized cardiac event rate was 1% in all CAC subgroups, including those with CAC scores 1,000.
Kaplan-Meier analysis revealed similarly low cardiac event rates among nonischemic patients with CAC scores
1,000 and nonischemic patients with Bayesian coronary artery disease likelihood 85%. Late myocardial re-
vascularization rates were also similar in these 2 groups.
Conclusions Among patients with nonischemic MPS studies, high CAC scores do not confer an increased risk for cardiac
events. Thus, although patients with high CAC scores may be considered for intensive medical therapy to prevent
future coronary artery disease events, a normal MPS study in such patients suggests no need for more aggres-
sive interventions. (J Am Coll Cardiol 2007;49:1352–61) © 2007 by the American College of Cardiology
Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2006.12.035n
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(he clinical management of patients suspected of hav-
ng angiographically significant coronary artery disease
ASCAD) is often aided by the performance of stress tests,
uch as myocardial perfusion scintigraphy (MPS). For
nstance, because a normal exercise MPS study reliably
ignifies a low annualized risk of major cardiac events
mong patients with even a high Bayesian pre-MPS likeli-
ood of ASCAD (1), it is generally reasonable to employ
onservative medical management when such patients are
rom the *Department of Medicine, St. Luke’s Roosevelt Hospital, New York, New
ork; †Departments of Imaging and Medicine and the Burns and Allen Research
nstitute, Cedars-Sinai Medical Center, and the Department of Medicine, David
effen School of Medicine, University of California, Los Angeles, California; and the
Heart Disease Prevention Program, University of California, Irvine, California. This
tudy was supported by a grant from The Eisner Foundation, Los Angeles, California.d
Manuscript received August 22, 2006; revised manuscript received November 22,
006, accepted December 8, 2006.onischemic. By contrast, because the likelihood of cardiac
vents increases exponentially according to the magnitude of
schemia (2), patients with moderate-to-severe ischemia
enerally deserve aggressive interventions. These robust
rognostic associations help account for the current ubiqui-
ous use of cardiac stress testing in clinical practice.
Recently, coronary artery calcium (CAC) scanning has been
dvocated as a new method for risk stratifying patients at
ntermediate risk for ASCAD. Atherosclerotic lesions are
requently associated with the presence of calcium (3,4), which
an be accurately detected using computed tomography and
uantified according to calcium (5), volume (6), and percentile
alcium scores (7). Measurements of CAC have been shown to
redict the underlying magnitude of atherosclerotic burden
8–10), the frequency of stress-induced myocardial ischemia
11,12), and the likelihood of future cardiac events in longitu-
inal studies (13–18). To date, however, this newer method of
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March 27, 2007:1352–61 Outcomes After Calcium Scans and Exercise MPSisk stratification has not been compared directly to cardiac
tress testing for prognostic purposes. Thus, there is as yet no
nformation to guide physicians in their clinical assess-
ent and subsequent management of patients who have
ndergone both forms of testing. Perhaps most puzzling
ay be the following question: do high CAC scores, an
ndicator of increased long-term risk, still confirm an
ncreased likelihood of future cardiac events in patients
ith nonischemic MPS studies, an indicator of low risk?
o address this issue, we undertook a study that com-
ares 3-year outcomes among patients undergoing both
xercise MPS and CAC scanning.
ethods
tudy population. Two patients groups at Cedars-Sinai
edical Center (CSMC) were evaluated. The first group
the “CAC” group) consisted of 1,153 patients followed for
1 year after undergoing dual isotope exercise MPS and
AC scanning within 6 months of each other (mean of 24
38 days), between April 1998 and January 2005. This
AC group included a mixed sample of 702 patients (61%)
ho were physician-referred for CAC scanning, 92 (8%)
ho were self-referred, and 359 (31%) who underwent
canning as part of an ongoing research protocol (Early
dentification of Subclinical Atherosclerosis by Noninvasive
maging Research Study). Coronary artery calcium scanning
as performed before MPS in 517 (55%) patients and on
he same day or after MPS in 636 (55%) patients. The
econd group (hereafter referred to as the “MPS” group)
onsisted of 9,308 patients followed for 1 year after
ndergoing MPS on a clinical basis between March 1991
nd September 1999. Patients with known coronary artery
isease (CAD), valvular disease, or known cardiomyopathy
ere excluded. This MPS referent group allowed us to
nvestigate whether there is a parallel between the prognos-
ic relationship between CAD likelihood values and MPS
esults and CAC values and MPS results, in light of data
ndicating that CAC increases patients’ Bayesian likelihood
or CAD (19). This research was approved by the CSMC
nstitutional Review Board, and all patients signed in-
ormed consent.
tress testing and imaging protocol. Patients were in-
ected intravenously at rest with thallium-201 (3 mCi to 4
Ci). After rest MPS, patients underwent symptom-
imited Bruce protocol treadmill exercise testing, with a 20
Ci to 30 mCi dose of technetium-99m sestamibi injected
t near maximal exercise, and MPS imaging was then
epeated. The MPS studies were acquired using elliptical
80° orbits and standard energy windows (19). Scintigrams
ere assessed semiquantitatively by visual interpretation of
0 myocardial segments according to a 5-point score, and
ummed scores were compared at stress and rest (20). A
ummed difference score 4, corresponding to 5% of the
yocardial segments with reversible defect (21), defined theresence of ischemia. galcium scanning. Scanning
as performed using either elec-
ron beam (EBT) (Imatron
-150 or GE eSpeed, General
lectric, Milwaukee, Wisconsin)
n  934 patients) or multislice
omputed tomography (MSCT)
n  219 patients), with acquisi-
ions consisting of approximately
0 to 40 3-mm or 2.5-mm slices
or the 2 tomographic systems,
espectively (12). Foci of coro-
ary artery calcification were
dentified and scored by an expe-
ienced technician, blinded to
oth patient characteristics and
he MPS results, using semiau-
omatic commercial software on
NetraMD workstation (ScImage, Los Altos, California)
y detection of at least 3 contiguous pixels (voxel size 1.03
m3) of peak density 130 HU within a coronary artery,
ith scoring verified by an experienced imaging cardiologist.
oronary artery calcium scores were calculated according to
he method of Agatston et al. (5), and age- and gender-
djusted CAC percentile scores were determined according
o the database of Raggi et al. (7).
ikelihood of CAD. The likelihood of ASCAD, exclusive
f the MPS results, was calculated for each patient based on
he Bayesian analysis of patients’ age, gender, risk factors,
hest pain symptoms, and results of exercise electrocardiog-
aphy according to a previously validated commercial soft-
are program (CADENZA, Advanced Heuistics, Bain-
ridge Island, Washington) (22).
ollow-up. Patients were followed for the occurrence of
ard cardiac events, which included either the occurrence of
ardiac death, as noted and confirmed by a review of death
ertificate and hospital chart or physician’s record, or myo-
ardial infarction, as evidenced by the appropriate combi-
ation of patients’ signs and symptoms and enzyme eleva-
ions (23). In addition, we identified if patients underwent
ardiac catheterization or coronary revascularization proce-
ures (coronary bypass or percutaneous coronary interven-
ions), and defined these as “early” if they occurred60 days
f noninvasive testing and “late” if they occurred 60 days
fter testing. The performance of late myocardial revascu-
arization was a secondary end point in this study based on
ts use as a proxy variable for worsening clinical status (24).
s previously described (25), initial patient follow-up was
btained by searching our hospital-based information sys-
em (WebVS) as well as the Social Security Death Index.
ollow-up in the remaining patients was sought through a
ailed questionnaire or a scripted telephone interview. To
scertain the cause of death, the information provided by
ebVS and the death certificates obtained for all those who
ied in Los Angeles County were reviewed by 2 cardiolo-
Abbreviations
and Acronyms
ASCAD  angiographically
significant coronary artery
disease
CAC  coronary artery
calcium
CAD  coronary artery
disease
CSMC  Cedars-Sinai
Medical Center
EBT  electron beam
computed tomography
MPS  myocardial
perfusion scintigraphy
MSCT  multislice
computed tomographyists blinded to subjects’ clinical information. Death from
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Outcomes After Calcium Scans and Exercise MPS March 27, 2007:1352–61ardiac causes was defined as death from any cardiac cause
e.g., lethal arrhythmia, myocardial infarction, or pump
ailure).
tatistical analysis. Continuous variables were compared
sing t tests or nonparametric Wilcoxon rank sum tests,
epending on whether or not the assumptions for the test
ere met, whereas categorical variables were compared
sing the chi-square test. Chi-square test for trend was
sed when appropriate. Time to follow-up or events was
alculated from the date of the second test to either the
ollow-up time or time of the first event. Early revascu-
arizations 60 days were censored, except as noted.
aplan-Meier survival curves were generated, and com-
ared using the log-rank test. Cox proportional hazards
urvival models, risk adjusted for mean age, gender,
yspnea, and various coronary risk factors, were also
enerated. The Kaplan-Meier survival curves were com-
ared using the log-rank test. The CAC group was
ivided for this purpose into 3 subgroups: those with
AC scores 400, 400 to 999, and 1,000. Similarly,
he MPS group was also divided into 3 groups based on
AD likelihood values, according to a commonly used
ivision: those with “low” (15%), “intermediate” (15%
o 84%), and “high” (85%) CAD likelihood values (1).
ecause of clinical differences in the CAC cohort and
PS cohorts, subgroups were selected using patient
Comparison of the CAC and MPS Patient Group
Table 1 Comparison of the CAC and MPS P
Parameters CAC Gro
Age (yrs) 58
Males 8
Symptoms
Asymptomatic 5
Nonanginal chest pain
Atypical angina 3
Typical angina
Dyspnea only
Mean ASCAD likelihood 25
Coronary risk factors
History of high cholesterol 7
History of hypertension 4
Smoking
Diabetes
Family history 2
Mean number of risk factors 1
Hemodynamics and exercise test responses
Peak heart rate (beats/min) 15
Peak SBP (mm Hg) 17
Peak DBP (mm Hg) 7
Exercise duration (min)
Exercise chest pain
Ischemic ECG 2
Ischemic MPS
Values are expressed as n (%) or mean  SD.
ASCAD  angiographically significant coronary artery disease; C
electrocardiogram; MPS  myocardial perfusion scintography; SBP atching techniques based on propensity scores that tatched patients from the CAC cohort to patients from
he MPS cohort on age, gender, absence of chest pain
ymptoms, shortness of breath, pre-MPS likelihood of
SCAD, and exercise duration (26). The propensity-
atched groups were compared using either the paired t
est in the case of exercise duration or the nonparametric
ilcoxon signed rank test for all continuous variables,
hereas the McNemar test was used to compare the
ategorical variables.
esults
or the CAC group, a total of 1,190 patients met
nclusion criteria for our study. Of these, 37 patients (3%)
ere lost to follow-up, resulting in a study population of
,153 patients. The mean (SD) duration of follow-up
n this group was 32  16 months (range 12 to 76
onths). For the MPS group, a total of 9,757 patients
et inclusion criteria for this study. Of these, 449
atients (5%) were also lost to follow-up, resulting in a
tudy population of 9,308 patients. The mean (SD)
uration of follow-up in this group was 35  25 months
range 12 to 152 months). The clinical characteristics in
ur CAC and MPS groups are listed in Table 1. Patients
n the CAC group were younger and contained more
symptomatic patients than those in the MPS group, but
t Groups
 1,153) MPS Group (n  9,308) p Value
0.0 61.2  12.4 0.0001
%) 5,530 (59%) 0.001
%) 2,845 (31%)
) 2,283 (25%)
%) 2,722 (29%)
) 1,068 (11%)
) 390 (4%) 0.001
1.9 30.9  33.3 0.0001
%) 4,062 (44%) 0.001
%) 3,894 (42%) 0.02
) 1,291 (14%) 0.001
) 943 (10%) 0.02
%) 2,213 (24%) 0.70
.9 1.3  1.0 0.01
5 149  18 0.0001
0 179  26 0.0001
0 84  13 0.0001
7  3 0.0001
) 1,170 (13%) 0.001
%) 2,182 (23%) 0.09
) 1,765 (19%) 0.0001
coronary artery calcium; DBP  diastolic blood pressure; ECG 
c blood pressure.s
atien
up (n
.4  1
56 (74
83 (51
96 (8%
83 (33
44 (4%
47 (4%
.4  3
48 (65
40 (38
75 (7%
92 (8%
68 (23
.4  0
4  1
2  2
7  1
9  3
96 (8%
45 (21
64 (6%he 2 groups only differed modestly in terms of mean
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March 27, 2007:1352–61 Outcomes After Calcium Scans and Exercise MPSSCAD likelihood and the mean number of CAD risk
actors. Various exercise parameters, such as exercise
uration, also differed between the 2 groups, and there
as a substantially greater frequency of detected ischemia
n the MPS group.
requencies of ischemia, revascularization rates, and
ardiac events according to CAC score. As indicated in
able 2, the frequency of inducible ischemia rose pro-
ressively with increasing CAC scores in the CAC group.
ithin this group, a high percentage of those patients
aving inducible ischemia underwent early coronary re-
ascularization compared with the patients without in-
ucible ischemia (42.2% vs. 0.3%, p  0.0001). Accord-
ngly, follow-up results for patients grouped according to
evel of CAC score in Table 2 are presented separately for
he ischemic and nonischemic patients. Overall, only 64
5.6%) patients had inducible ischemia, precluding any
ignificant prognostic assessments in this patient subgroup.
mong these ischemic patients, 38 (59%) had mild isch-
mia (i.e., summed reversibility score of 4 to 8, or involving
% to 10% of the myocardium), whereas 26 (41%) patients
ad more moderate-to-severe ischemia (i.e., summed re-
ersibility scores 8, involving 10% of the myocardium).
he mean percentage of ischemic myocardium was signif-
cantly greater among the 27 patients who underwent early
yocardial revascularization compared with the 37 who did
ot (13.9  8.7% vs. 9.0  4.5%, p  0.01).
Among the nonischemic CAC patients, the frequency of
eferral to cardiac catheterization, early and late revascular-
zations, and cardiac events rose with increasing CAC
cores, but the annualized frequency of cardiac events were
requency of Revascularization Procedures and Cardiac Events Dur
Table 2 Frequency of Revascularization Procedures and Cardia
Groups 0 1–9 10
All CAC patients (n  1,153)
Patients (n) 252 52 2
% ischemia 1.2% 1.9% 1
Ischemic (n  64)
Ischemic patients (n) 3 1
Early cath (60 days) 1 (33%) 1 (100%) 1 (3
Revascularized 60 days 0 (0%) 0 (0%) 0 (0
Revascularized 60 days 0 (0%) 0 (0%) 0 (0
CD/MI* 0 (0%) 0 (0%) 0 (0
Annualized CD/MI rate 0%/yr 0%/yr 0%
Nonischemic (n  1,089)
Nonischemic patients (n) 249 51 2
Early cath (60 days) 2 (0.8%) 1 (2.0%) 0 (0
Revascularized 60 days 0 (0%) 0 (0%) 0 (0
Revascularized 60 days 2 (0.8%) 0 (0%) 6 (3
CD/MI* 1 (0.4%) 0 (0%) 0 (0
Annualized CD/MI rate 0.2%/yr 0%/yr 0%
p Values for annualized cardiac death (CD)/myocardial infarction (MI) event rates were derived us
atients with early revascularization were censored.
Abbreviations as in Table 1.uite modest, even among those with high CAC scores. We erformed Kaplan-Meier survival curve analysis in these
onischemic CAC patients, after dividing them according
o their magnitude of CAC (Fig. 1). Excluding early
evascularizations, the event-free survival was 95% over
he first 4 years of follow-up for each of these nonischemic
AC subgroups, and only small, but statistically significant,
ifferences were observed in event-free survival according to
he level of CAC. After adjusting for clinical factors, the
ifferences in outcome among the 3 CAC subgroups were no
onger significant. Thus, in the absence of inducible ischemia,
he presence of higher CAC scores was still associated with a
ow risk of cardiac events during our 4-year follow-up.
There was no difference in cardiac event rates among
atients who were referred for CAC scanning for clinical
ersus research purposes or for those who were scanned
sing EBT versus MSCT.
requencies of ischemia, revascularization rates, and
ardiac events in the MPS referral cohort. As ASCAD
ikelihood increased, so did the frequency of inducible
yocardial ischemia (Table 3). Among the MPS patients
anifesting inducible ischemia, 27.7% underwent myocar-
ial revascularization procedures, compared with only 0.4%
mong the patients with nonischemic MPS studies (p 
.0001). Among the ischemic MPS patients, the frequency
f revascularization procedures rose with increasing
SCAD likelihood, but the frequency of cardiac events did
ot. Among these patients, the percent ischemic myocar-
ium was significantly greater in the 489 patients who
nderwent early myocardial revascularization compared
ith the 1,276 patients who did not (19.4  10.0% vs. 11.6
ollow-Up Results in the CAC Cohort
nts During Follow-Up Results in the CAC Cohort
AC Grouping
p Value*100–399 400–999 >1000
274 230 140
4.0% 7.8% 20.0% 0.0001
11 18 28
6 (55%) 11 (61%) 13 (46%) 0.99
5 (46%) 9 (50%) 13 (46%) 0.06
1 (9.1%) 1 (5.6%) 3 (10.7%) 0.41
0 (0%) 0 (0%) 2 (7.1%) 0.23
0%/yr 0%/yr 2.7%/yr 0.88
263 212 112
5 (1.9%) 3 (1.4%) 6 (5.4%) 0.01
0 (0%) 0 (0%) 3 (2.7%) 0.007
6 (2.3%) 11 (5.2%) 7 (6.3%) 0.001
2 (0.8%) 6 (2.8%) 2 (1.8%) 0.02
0.3%/yr 1.0%/yr 0.6%/yr 0.10
log-rank test; all other p values are chi-square test for trend. For the annualized CD/MI event rates,ing F
c Eve
C
–99
05
.5%
3
3%)
%)
%)
%)
/yr
02
%)
%)
.0%)
%)
/yr
ing the7.4%, p  0.0001).
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Outcomes After Calcium Scans and Exercise MPS March 27, 2007:1352–61In the nonischemic MPS patients, the frequency of
ardiac catheterization referral, early and late revascular-
zations, and cardiac events also rose with increasing
SCAD likelihood, but the differences among the
SCAD likelihood subgroups were modest. As seen for
he nonischemic CAC patients grouped according to
heir CAC scores, the event-free survival was 95% over
he first 4 years of follow-up for each of the ASCAD
ikelihood subgroups among the nonischemic MPS pa-
Figure 1 Cardiac Events According to CAC Scores
Survival curves for freedom from cardiac death or nonfatal myocardial infarction (M
cise myocardial perfusion scintigraphy studies. (Left) Kaplan-Meier survival curve a
p value is derived using the log-rank test. (Right) Cox proportional hazards model
factors. The p value is that of CAC in the Cox risk-adjusted model. Patients with ea
litus; SOB  shortness of breath.
requency of Revascularization Procedures and Cardiac Events Dur
Table 3 Frequency of Revascularization Procedures and Cardia
Groups
Baye
<15% CAD LL
All MPS patients (n  9,308)
Patients (n) 4,604
% ischemic 9.5%
Ischemic (n  1,765)
Ischemic patients (n) 435
Early cath (60 days) 132 (30%)
Revascularized 60 days 60 (14%)
Revascularized 60 days 36 (8.3%)
No. with CD/MI* 21 (4.8%)
Annualized CD/MI rate 1.6%/yr
Nonischemic (n  7,543)
Nonischemic patients (n) 4,169
Early cath (60 days) 61 (1.5%)
Revascularized 60 days 8 (0.2%)
Revascularized 60 days 66 (1.6%)
CD/MI* 22 (0.5%)
Annualized CD/MI rate 0.2%/yr
The p values for annualized cardiac death (CD)/myocardial infarction (MI) event rates were derive
ates, patients with early revascularization were censored.
CAD  coronary artery disease; LL  likelihood.ients (Fig. 2). Before adjustment for significant covari-
tes, there was a small but statistically greater cardiac
vent rate among the nonischemic MPS patients with
SCAD likelihood 85%, but this ASCAD subgroup
o longer had a lower cardiac event rate than the other
SCAD likelihood subgroups after risk adjustment.
omparison of cardiac event rates among matched non-
schemic CAC and MPS patients. In order to compare
he relative frequency of cardiac event rates among the
xis) among the coronary artery calcium (CAC) patients who had nonischemic exer-
is as a function of CAC scores before adjustment for covariates of outcome. The
edom from cardiac death or MI risk adjusted for age, dyspnea, and coronary risk
ocardial revascularization were censored from the analysis. DM  diabetes mel-
ollow-Up in the MPS Referral Cohort
nts During Follow-Up in the MPS Referral Cohort
AD Likelihood Grouping
p Value*%–84% CAD LL >85% CAD LL
02 1,202
19.8% 52.9% 0.0001
94 636
76 (40%) 331 (52%) 0.0001
73 (25%) 256 (40%) 0.0001
76 (11%) 83 (13%) 0.01
29 (4.2%) 28 (4.4%) 0.78
1.4%/yr 1.5%/yr 0.85
08 566
69 (2.5%) 21 (3.7%) 0.0001
14 (0.5%) 6 (1.1%) 0.0007
01 (3.6%) 56 (9.9%) 0.0001
35 (1.3%) 17 (3.0%) 0.0001
0.4%/yr 1.0%/yr 0.0001
the log-rank test; all other p values are chi-square test for trend. For the annualized CD/MI eventI) (y-a
nalys
for fre
rly mying F
c Eve
sian C
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3,5
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March 27, 2007:1352–61 Outcomes After Calcium Scans and Exercise MPSonischemic CAC and MPS patients, we performed a 1:1
ropensity matching, based on patient’s age, gender,
istribution of type of chest pain symptoms, mean
SCAD likelihood values, and exercise duration. Both
roups included 1,025 patients (Table 4), who differed
Figure 2 Cardiac Events According to ASCAD LL
Survival curves for freedom from cardiac death or nonfatal myocardial infarction (M
ischemic exercise MPS studies. (Left) Kaplan-Meier survival curve analysis as a fu
(CAD). (Right) Cox risk-adjusted model for freedom of cardiac death or MI risk adj
omparison of Patient Populations
Table 4 Comparison of Patient Populations
Parameters
Propensity-Matched C
(n  1,025
Age* 58.2 10.
Males* 756 (73.8%
Symptoms
Asymptomatic* 540 (52.7%
Nonanginal chest pain 87 (8.5%)
Atypical angina 331 (32.3%
Typical angina 26 (2.5%)
Dyspnea only* 41 (4.0%)
Mean ASCAD likelihood* 22.6 29.
Coronary risk factors
History of high cholesterol 670 (65.4%
History of hypertension 380 (37.1%
Smoking 66 (6.4%)
Diabetes 73 (7.1%)
Family history 242 (23.6%
Mean number of CRFs 1.4 0.9
Hemodynamics and exercise test responses
Peak heart rate 154.9 14.
Peak SBP 171.8 20.
Peak DBP 76.9 9.4
Exercise duration* 9.4 2.7
Maximally predicted HR 95.5 6.9
Exercise chest pain 69 (6.7%)
Ischemic ECG 194 (18.9%Normal SPECT patients were matched on these variables. Values are expressed as n (%) or mean  SD
Abbreviations as in Table 1.tatistically only in terms of dyspnea, diastolic blood
ressure measurements, certain CAD risk factors, and
requency of ischemic exercise electrocardiogram re-
ponses. Figure 3 demonstrates that the overall frequency
f cardiac events was very similar in the propensity-
ng the myocardial perfusion scintigraphy (MPS) referral subgroup who had non-
of the likelihood (LL) of angiographically significant coronary artery disease
for age, dyspnea, and coronary risk factors. Other abbreviations as in Figure 1.
roup Propensity-Matched MPS Group
(n  1,025) p Value
58.4 11.9 0.68
764 (74.5%) 0.70
536 (52.3%) 0.88
176 (17.2%) 0.0001
181 (17.7%) 0.0001
49 (4.8%) 0.01
83 (8.1%) 0.94
22.1 28.9 0.54
417 (40.7%) 0.0001
359 (35.0%) 0.35
146 (14.2%) 0.0001
70 (6.8%) 0.86
244 (23.8%) 0.96
1.2 1.0 0.0001
154.0 17.6 0.17
181.7 24.9 0.0001
83.8 12.5 0.0001
9.4 2.8 0.93
95.3 8.0 0.49
55 (5.4%) 0.23
252 (24.6%) 0.002I) amo
nction
ustedAC G
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Outcomes After Calcium Scans and Exercise MPS March 27, 2007:1352–61atched nonischemic CAC and MPS patients. When
hose with the highest CAC scores (1,000) were
ompared with each of the ASCAD likelihood subgroups
ithin the propensity-matched MPS cohort, there was
o statistical difference in the frequency of cardiac events.
requency of late myocardial revascularizations. As
hown in Figure 4, event-free survival according to the
econdary end point of late myocardial revascularization
ecreased with both increasing CAC scores in the nonisch-
mic CAC subgroup and with increasing ASCAD likeli-
Figure 3 Comparison of Outcomes Among Patient Groups
(Left) Kaplan-Meier survival curves for freedom from cardiac death or myocardial i
sion scintigraphy (MPS) cohorts who had no ischemia during stress MPS testing. (
nary artery disease likelihood (LL) values 15%, 15% to 85%, and 85% and for
subgroups.
Figure 4 Comparison of Rates for Late Revascularization
(Left) Kaplan-Meier curves for freedom from late myocardial revascularization amo
scintigraphy (MPS). (Right) Kaplan-Meier curves for freedom from late myocardial
ease; LL  low likelihood.ood in the nonischemic MPS subgroup. Comparison of
he Kaplan-Meier event-free survival curves in the patients
ith high ASCAD likelihood to those with CAC scores
1,000 revealed no statistical difference in the frequency of
ate coronary revascularizations over time.
iscussion
ecent follow-up studies demonstrate a proportional
elationship between CAC scores and the frequency of
on in the propensity-matched coronary artery calcium (CAC) and myocardial perfu-
Kaplan-Meier survival curves for the propensity-matched MPS patients with coro-
tients with CAC scores 1,000. There were no statistical differences among the
coronary artery calcium (CAC) patients having nonischemic myocardial perfusion
ularization among the nonischemic MPS patients. CAD  coronary artery dis-nfarcti
Right)
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cores increased, so too did the frequency of inducible
yocardial ischemia. Since myocardial ischemia is a
otent predictor of future cardiac events (1,2), our results
ould appear to be concordant with follow-up studies
oncerning CAC scanning.
Prior epidemiologic studies have largely assessed the role
f CAC scanning in screening populations but not the
ypical diagnostic patients that are referred for cardiac stress
esting. However, because high CAC scores have now
ecome a potential reason for referring patients for cardiac
tress testing (11,12), there is an increasing need to under-
tand the prognostic interrelationship between CAC scores
nd measurement of inducible myocardial ischemia. Ac-
ordingly, in this study, we evaluated cardiovascular out-
omes among patients who underwent both CAC testing
nd exercise MPS in close temporal proximity. In our
opulation, revascularization was driven by the presence of
yocardial ischemia on MPS imaging, but very few patients
ith normal MPS underwent revascularization, even when
he CAC score was very high. This practice, which probably
eflected our physicians’ confidence in the prognostic sig-
ificance of a normal MPS study, resulted in a unique
pportunity for us to examine the interrelationship between
anatomic” evidence of CAD and physiology, namely how
linical outcomes vary according to a wide spectrum of
AC scores among patients without evidence of inducible
schemia, as measured during MPS. Our findings indicate
hat the magnitude of CAC exerted little influence upon
utcomes among the patients who did not have inducible
schemia during MPS. Most notably, among the nonisch-
mic patients with CAC scores 1,000, the frequency of
ardiac death or myocardial infarction over 3 years of
ean follow-up was 2%, thus yielding an annualized
ardiac event rate of 1%.
Among patients with inducible myocardial ischemia,
ubsequent referral to cardiac catheterization is common-
lace. In our study, 42% of CAC patients with inducible
yocardial ischemia underwent early myocardial revascular-
zation, with larger perfusion defects in these patients than
hose observed among ischemic patients who did not
ndergo myocardial revascularization. This “interventional
eferral bias” is the likely explanation for why cardiac event
ates did not increase among our ischemic MPS subgroup as
he likelihood of ASCAD increased. Similarly, because of
his referral bias, we could not assess whether CAC scores
dded incremental information for predicting patient out-
omes among patients with inducible myocardial ischemia.
Previous work by Budoff et al. (19) has suggested that
rogressively higher CAC scores increase the Bayesian
ikelihood of ASCAD, but complementary observations
ndicate that the likelihood of cardiac events still remains
1% for nonischemic MPS patients with a high Bayesian
ikelihood of CAD (1,23). Accordingly, we reasoned that
here may be a parallel between outcomes observed in
onischemic patients who are stratified on the basis of rSCAD likelihood and those who are stratified on the basis
f CAC scores. To assess this possibility, we also evaluated
ardiac outcomes in a large series of patients who underwent
xercise MPS studies in our laboratory, but from an earlier
onoverlapping period relative to the current recruitment of
PS patients for CAC scanning. Among the MPS patients
ithout inducible ischemia, only a small increase in cardiac
vents occurred as the likelihood of ASCAD increased from
mall to high likelihood estimates, paralleling the pattern
oted for CAC scores. Moreover, the frequency of cardiac
vents remained similarly low in the propensity-matched
AC and MPS subgroups that did not have inducible
schemia during exercise testing, including the subgroup of
atients with CAC scores 1,000.
athophysiological considerations. The induction of
yocardial ischemia is the end result of not only angio-
raphic stenoses but also pathophysiological factors, such as
he degree of endothelial dysfunction, which can influence
he adequacy of myocardial perfusion during physiological
timulation (27,28) and contribute to the magnitude of
erfusion defects observed during exercise MPS (29,30).
or this reason, the assessment of myocardial perfusion
uring stress MPS complements both angiographic mea-
urements (31,32) and Bayesian estimations of ASCAD
ikelihood in the prediction of cardiac events (1,23). The
resence of higher levels of CAC is a marker of greater
therosclerotic burden (8,9), but whether CAC scores also
eflect greater functional abnormalities known to be associ-
ted with adverse cardiac events is not presently clear. A
ecent study (33) suggests that higher CAC scores signify a
reater magnitude of endothelial dysfunction, but CAC
easurements correlate relatively poorly, for example, with
-reactive protein levels, a measure of systemic inflamma-
ion (18,34). Although we observed a progressively higher
requency of inducible perfusion defects as CAC scores
ncreased, our study did not assess pathophysiological ab-
ormalities that may govern this association. However, our
ollow-up results suggest that the inherently greater risk that
ay be associated with higher CAC scores may be identi-
ed by evaluating such patients for inducible myocardial
schemia.
Various cohorts of patients have been identified who
ppear to have a heightened risk of cardiac events in the
resence of a normal MPS study. These include diabetic
atients (35), patients with atrial fibrillation (36), and
atients complaining of dyspnea (24). Our data, however,
uggests that a high CAC score is not an additional factor
hat heightens short-term risk in the presence of a normal
PS study.
tudy limitations. A number of limitations should be
onsidered. First, because our CAC group had a low event
ate with only 11 hard cardiac events, the small but
tatistically significant increase in hard cardiac events among
onischemic patients with high CAC scores would need
dditional study in larger samples to further assess the
obustness of our findings. Second, a recent study (37) has
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fy the relationship between CAC scores and myocardial
schemia, but these and other potential modifying factors
ere not assessed in this study. One recent study (38)
xamined the prognostic relationship between CAC scores
nd MPS in type II diabetics, but the smaller sample size
nd event rate in that study, as well as its lack of a
ondiabetic control group, precluded comparisons to our
tudy. Third, comparison of our CAC to MPS cohorts was
imited by differences in the clinical characteristics of these
groups, and also by differences in temporal recruitment.
e overcome this issue, in part, by limiting our compari-
ons to propensity-matched cohorts, but this matching did
ot take into account important advances in the therapeutic
anagement of nonischemic patients over the last decade.
evertheless, this limitation does not detract from the
eneral principle that we demonstrated in this study: neither
igh ASCAD likelihood values nor high CAC scores
ppear to constitute a pattern of increased prognostic risk in
he presence of a nonischemic exercise MPS study. Finally,
ur study does not exclude the possibility of higher CAC
cores reducing the “warranty period” associated with a
ormal MPS as patients are followed over longer time
ntervals.
linical relevance. Although CAC scanning has shown
romise as a means for risk stratifying patients with
elatively low likelihood of ASCAD (13–18), the cost of
uch scanning is not widely covered by third-party
nsurers. A variety of factors may govern the current
imited acceptance of this technology, including concern
hat it may lead to a substantial increase in further
iagnostic tests and related healthcare costs. On the other
and, it is also possible that the judicious use of this
echnology could improve the risk assessment and man-
gement of patients in certain clinical subgroups in a
ost-effective manner. For example, whereas a persistent
rend to refer many patients with only a low likelihood of
SCAD for stress MPS studies has been documented
39), application of CAC scanning in such patients could
otentially reduce the number of such patients who are
hen referred for MPS studies by preferentially limiting
PS referral to those patients with relatively higher
AC scores (12). However, support for such potential
ractice requires determination of the appropriate man-
gement for patients identified as having high CAC
cores but nonischemic MPS studies. Our findings sug-
est that patients with this combination of findings are
nlikely to benefit from myocardial revascularization
rocedures. Prospective study is required to determine
hether a strategy of applying CAC scanning to patients
ith a low-to-intermediate likelihood of ASCAD, fol-
owed by the performance of MPS in those with a
ufficiently elevated CAC score and reserving coronary
ngiography referrals for patients with inducible myocar-
ial ischemia, represents a cost-effective strategy for
anaging patients.eprint requests and correspondence: Dr. Daniel S. Berman,
irector of Cardiac Imaging, Cedars-Sinai Medical Center, 8700
everly Boulevard, Room 1258, Los Angeles, California 90048.
-mail: bermand@cshs.org.
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